Gene · 780
Papers2,465
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 2,465
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evolution of kinase polypharmacology across HSP90 drug discovery. | Cell Chem Biol | 2021 | 34077750 | PubTator, text mining | PubMed |
| Association between Interferon-Lambda-3 rs12979860, TLL1 rs17047200 and DDR1 rs4618569 Variant Polymorphisms with the Course and Outcome of SARS-CoV-2 Patients. | Genes (Basel) | 2021 | 34071309 | PubTator, text mining | PubMed |
| Epigenetic Modulation of Radiation-Induced Diacylglycerol Kinase Alpha Expression Prevents Pro-Fibrotic Fibroblast Response. | Cancers (Basel) | 2021 | 34070078 | PubTator, text mining | PubMed |
| Influence of Tumor Microenvironment and Fibroblast Population Plasticity on Melanoma Growth, Therapy Resistance and Immunoescape. | Int J Mol Sci | 2021 | 34067929 | PubTator, text mining | PubMed |
| Collagen in Wound Healing. | Bioengineering (Basel) | 2021 | 34064689 | PubTator, text mining | PubMed |
| Targeting RTK-PI3K-mTOR Axis in Gliomas: An Update. | Int J Mol Sci | 2021 | 34063168 | PubTator, text mining | PubMed |
| Dasatinib-SIK2 Binding Elucidated by Homology Modeling, Molecular Docking, and Dynamics Simulations. | ACS Omega | 2021 | 34056256 | PubTator, text mining | PubMed |
| Tissue remodeling by invadosomes. | Fac Rev | 2021 | 34046643 | PubTator, text mining | PubMed |
| Anlotinib Combined With Chemotherapy for Recurrence of Pulmonary Sarcomatoid Cancer Previously Surgically Treated: A Case Report and Literature Review. | Front Oncol | 2021 | 34046343 | PubTator, text mining | PubMed |
| A 3D system to model human pancreas development and its reference single-cell transcriptome atlas identify signaling pathways required for progenitor expansion. | Nat Commun | 2021 | 34035279 | PubTator, text mining | PubMed |
| Role of the ABL tyrosine kinases in the epithelial-mesenchymal transition and the metastatic cascade. | Cell Commun Signal | 2021 | 34022881 | PubTator, text mining | PubMed |
| Current research on circular RNAs and their potential clinical implications in breast cancer. | Cancer Biol Med | 2021 | 34018386 | PubTator, text mining | PubMed |
| Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling Networks. | Cancer Res | 2021 | 34016623 | PubTator, text mining | PubMed |
| Transcriptome responses in polar cod (Boreogadus saida) liver slice culture exposed to benzo[a]pyrene and ethynylestradiol: insights into anti-estrogenic effects. | Toxicol In Vitro | 2021 | 34015484 | PubTator, text mining | PubMed |
| Utilizing graph machine learning within drug discovery and development. | Brief Bioinform | 2021 | 34013350 | PubTator, text mining | PubMed |
| Comment on "miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition". | Br J Cancer | 2021 | 34012034 | PubTator, text mining | PubMed |
| FOLFIRINOX-R study design: a phase I/II trial of FOLFIRINOX plus regorafenib as first line therapy in patients with unresectable RAS-mutated metastatic colorectal cancer. | BMC Cancer | 2021 | 34001059 | PubTator, text mining | PubMed |
| New insights into renal lipid dysmetabolism in diabetic kidney disease. | World J Diabetes | 2021 | 33995842 | PubTator, text mining | PubMed |
| Innovative Approaches in the Battle Against Cancer Recurrence: Novel Strategies to Combat Dormant Disseminated Tumor Cells. | Front Oncol | 2021 | 33987095 | PubTator, text mining | PubMed |
| DNA Methylation and Expression Profiles of Whole Blood in Parkinson's Disease. | Front Genet | 2021 | 33981329 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/780/papers?page=48